Olewniczak Sławomir, Chosia Maria, Kołodziej Blanka, Kwas Artur, Kram Andrzej, Domagała Wenancjusz
Department of Pathomorphology, Pomeranian Medical Academy, Szczecin.
Pol J Pathol. 2003;54(1):53-9.
The purpose of this study was to define the value of angiogenesis as a prognostic factor indicating early relapse. We assessed the relationship between parameters of angiogenesis (microvessel count--MVC, microvessel area--MVA and microvessel perimeter--MVP) and relapse-free survival at 50 months in 226 women with invasive ductal breast carcinoma. Anti CD31 antibody was used as a marker of endothelial cells. Microvessel density was measured according to Weidner et al. using a computerised image analysis. The mean parameters of angiogenesis were significantly higher in women with relapse than in those without recurrence within 50 months after surgery. In node negative patients relapse did not occur if MVC was below 38.7. In node-negative subgroup with grade II carcinomas parameters of angiogenesis in the primary tumour differed significantly depending on the presence or absence of relapse. Univariate and multivariate analysis showed the prognostic value of angiogenesis parameters in all study groups with respect to 50-month relapse-free survival. In node negative subgroup only 62.5% of women with tumors with high MVC and as much as 94.9% with low MVC survived 50 months without recurrence. In the Cox analysis of node-negative subgroup only MVC, MVP and MVA were the independent prognostic factors. In women with node-negative disease the evaluation of angiogenesis can identify a subgroup of patients with high risk of relapse, hence it may help in decisions concerning adjuvant therapy. Computerised image analysis is a good and objective technique for evaluating the intensity of angiogenesis in breast cancer.
本研究的目的是确定血管生成作为提示早期复发的预后因素的价值。我们评估了226例浸润性导管癌女性患者的血管生成参数(微血管计数——MVC、微血管面积——MVA和微血管周长——MVP)与50个月无复发生存率之间的关系。抗CD31抗体用作内皮细胞的标志物。微血管密度根据Weidner等人的方法,使用计算机图像分析进行测量。术后50个月内复发的女性患者的血管生成平均参数显著高于未复发的患者。在淋巴结阴性患者中,如果MVC低于38.7则不会发生复发。在II级癌的淋巴结阴性亚组中,原发性肿瘤的血管生成参数根据是否复发而有显著差异。单因素和多因素分析显示,血管生成参数在所有研究组中对50个月无复发生存率具有预后价值。在淋巴结阴性亚组中,MVC高的肿瘤患者只有62.5%存活50个月无复发,而MVC低的患者这一比例高达94.9%。在淋巴结阴性亚组的Cox分析中,只有MVC、MVP和MVA是独立的预后因素。对于淋巴结阴性疾病的女性患者,血管生成评估可以识别出复发风险高的亚组患者,因此有助于辅助治疗决策。计算机图像分析是评估乳腺癌血管生成强度的一种良好且客观的技术。